Primary Care / Neurology

Optimal Pharmacologic Treatment of ADPKD: What You Need to Know

CME: 0.75

December 31, 2021
/ Print / Reprints /
| Share More
/ Text Size+


On completion of this activity, the learner will be better able to:

  • Apply evidence-based principles to select patients with ADPKD who are appropriate for disease-modifying therapy¬†
  • Describe the optimal use of REMS programs to improve safety and patient outcomes¬†
  • Employ strategies to mitigate risk when initiating and monitoring pharmacologic therapy for ADPKD

Post a comment to this article